RAPP·75383L102·US·equity·Healthcare - Biotechnology-Activist
RAPP (RAPPORT THERAPEUTICS INC) is held by 86 institutional investors as of Q1 2026. Largest holders: FMR LLC ($224.3M), Capital International Investors ($96.9M), GOLDMAN SACHS GROUP INC ($92.1M). Net institutional sentiment: Mixed.
See how RAPP's score breaks down across 4 SEC sources
Showing 1-20 of 95
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer